Telix Pharmaceuticals
TLX.AX
$25.06
Share price
-1.43%
Change (1 day)
139.03%
Change (1 year)
Categories
Revenue for Telix Pharmaceuticals (TLX.AX)
Revenue in 2023: C$0.48 Billion
According to Telix Pharmaceuticals's latest financial reports the company's current revenue (TTM 
) is C$0.48 Billion. In 2023 the company made a revenue of C$0.48 Billion an increase over the revenue in the year 2022 that were of C$0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Telix Pharmaceuticals from 2018 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 | C$0.48 B | 218.78% |
| 2022 | C$0.15 B | 2889.27% |
| 2021 | C$5.1 M | -1.32% |
| 2020 | C$5.17 M | 47.48% |
| 2019 | C$3.5 M | 1674.89% |
| 2018 | C$0.19 M |